Interpace Biosciences IDXG Balance Sheet (2010-2026)

OTC IDXG
$6.00 -0.39 (-6.10%)
At close: Oct 2, 2026 · 4:00 PM EDT
Reported Financials

Interpace Biosciences Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Interpace Biosciences reported total assets of $34.55M and total liabilities of $11.30M for the quarter ended Jun 2026, up 180.1% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
3.20M2.67M2.85M1.86M6.31M4.83M5.60M5.08M5.03M3.50M2.81M0.50M1.40M1.46M1.20M0.50M1.42M2.50M2.65M2.70M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
3.20M2.67M2.85M1.86M6.31M4.83M5.60M5.08M5.03M3.50M2.81M0.50M1.40M1.46M1.20M0.50M1.42M2.50M2.65M2.70M
Receivables - NetNet Receivables
6.52M4.67M7.24M6.45M4.79M5.03M4.82M5.65M4.83M5.08M5.01M6.21M7.29M8.54M8.77M7.23M5.97M5.65M5.92M6.31M
Receivables - OtherOther Receivables
Receivables
6.52M4.67M7.24M6.45M4.79M5.03M4.82M5.65M4.83M5.08M5.01M6.21M7.29M8.54M8.77M7.23M5.97M5.65M5.92M6.31M
Inventory
2.27M0.82M2.06M2.01M1.25M1.22M1.17M1.18M1.09M1.23M1.15M1.23M1.22M1.21M1.21M0.97M1.10M1.11M0.96M1.08M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
0.73M0.58M0.61M0.58M0.23M0.39M0.33M0.64M0.44M0.59M0.39M0.67M0.44M0.54M0.40M0.73M0.58M0.63M0.43M0.19M
Current Assets
13.08M12.17M13.12M11.30M12.74M12.15M12.59M13.10M11.44M10.42M9.42M9.50M9.10M11.77M11.70M9.50M9.13M9.90M10.00M11.00M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
6.48M0.32M6.14M5.97M0.43M0.48M0.51M0.61M0.76M0.79M0.93M1.13M1.35M1.36M1.28M1.37M1.54M1.42M1.31M1.62M
Goodwill
8.43M8.43M8.43M8.43M
Intangibles
8.01M2.13M6.75M6.21M1.18M0.86M0.54M0.23M0.03M
Goodwill & Intangibles
16.45M10.56M15.18M14.65M1.18M0.86M0.54M0.23M0.03M
Long-Term Deferred Tax
21.25M20.98M20.91M
Other Non-Current Assets
0.30M0.14M0.15M0.13M0.08M0.18M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.08M0.07M0.05M0.04M0.04M0.04M
Non-Current Assets
27.22M26.26M25.24M24.19M2.55M3.83M3.39M2.97M2.81M2.70M2.73M3.47M4.94M3.02M2.79M2.83M2.91M23.94M23.41M23.55M
Assets
40.31M38.43M38.36M35.49M15.29M15.98M15.98M16.06M14.25M13.12M12.14M12.97M14.04M14.79M14.49M12.34M12.04M33.84M33.41M34.55M
Liabilities
Current Liabilities
Accounts Payables
2.43M1.37M3.95M3.52M1.45M1.05M1.58M1.69M1.35M1.54M1.36M1.76M1.70M1.66M1.73M1.25M1.41M0.98M0.81M1.55M
Notes Payables
7.87M5.10M7.50M6.78M5.69M4.29M2.77M1.77M0.98M
Payables
10.30M1.37M3.95M3.52M1.45M1.05M1.58M1.69M1.35M6.64M8.86M8.54M7.39M5.95M4.50M3.02M2.39M0.98M0.81M1.55M
Accumulated Expenses
Other Accumulated Expenses
9.04M8.46M8.69M8.79M8.38M8.42M3.28M2.98M8.81M2.16M2.20M1.83M1.89M1.80M1.70M1.42M1.45M1.57M1.78M1.78M
Short term Debt
2.00M2.50M2.50M2.20M1.50M
Current Leases
0.10M0.08M0.07M0.07M
Current Taxes
0.25M0.22M0.27M0.22M0.09M0.26M0.28M0.22M0.24M0.26M0.28M0.31M0.26M0.26M0.29M0.22M0.22M0.30M0.29M0.24M
Current Deferred Revenue
0.04M0.04M0.03M0.02M
Total Current Liabilities
22.84M15.68M16.90M18.45M14.81M14.28M8.81M8.16M12.32M11.44M12.60M7.10M5.90M10.62M8.70M7.15M5.95M5.10M4.00M5.00M
Non-Current Liabilities
Non-Current Debt
7.94M7.83M7.78M9.99M11.16M11.13M11.31M11.56M4.24M1.34M7.40M5.90M4.40M
Non-Current Deffered Revenue
0.02M0.01M0.01M0.01M
Preferred Stock Liabilities
46.54M46.54M46.54M46.54M46.54M46.54M46.54M46.54M46.54M46.54M46.54M46.54M46.54M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
0.77M766.000.77M0.77M
Operating Leases
3.15M0.52M2.93M2.69M0.18M1.85M1.75M1.65M1.56M1.47M1.36M1.29M1.19M1.18M1.08M0.97M0.86M0.75M0.64M0.52M
Other Non-Current Liabilities
4.77M4.58M4.68M4.72M4.74M4.70M4.78M4.86M4.95M4.97M5.07M5.15M5.23M5.21M5.32M5.42M5.53M5.62M5.73M5.84M
Total Non-Current Liabilities
74.19M76.27M78.01M78.72M72.15M69.37M68.59M67.88M66.03M63.69M61.84M60.10M59.35M11.80M9.76M8.12M6.81M5.86M4.60M5.47M
Total Liabilities
78.95M80.84M82.70M83.44M76.89M74.07M73.37M72.74M70.97M68.66M66.91M65.25M64.58M17.01M15.08M13.55M12.33M11.47M10.33M11.30M
Shareholder's Equity
Total Debt
7.87M7.94M7.83M9.78M12.49M13.66M13.33M12.81M11.56M9.34M8.84M14.18M11.59M8.69M2.77M1.77M0.98M
Common Equity
-38.65M-42.42M-44.34M-47.95M-61.59M-58.09M-57.39M-56.68M-56.72M-55.54M-54.77M-52.28M-50.54M-2.22M-0.58M-1.21M-0.30M22.36M23.08M23.24M
Liabilities and Shareholders Equity
40.31M38.43M38.36M35.49M15.29M15.98M15.98M16.06M14.25M13.12M12.14M12.97M14.04M14.79M14.49M12.34M12.04M33.84M33.41M34.55M
Treasury Shares
0.02M0.03M0.05M0.05M0.05M0.07M0.08M0.08M0.09M0.10M0.11M0.11M0.13M0.13M0.14M0.14M0.14M0.14M0.14M0.14M
Retained Earnings
-223.33M-227.06M-229.31M-233.25M-247.45M-249.02M-243.52M-242.96M-249.10M-242.08M-241.37M-238.94M-237.26M-235.38M-233.73M-234.37M-233.46M-210.81M-210.08M-209.93M

Interpace Biosciences Balance Sheet API

Pull Interpace Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IDXG&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY